ChtrA.00612.a
Lysine--tRNA ligase (LysS)
CENTER ID:
ChtrA.00612.a
ORGANISM:
Chlamydia trachomatis UCH-1/proctitis
ASSOCIATED DISEASE:
CURRENT STATUS:
in PDB
COMMUNITY REQUEST:
True
NIH RISK GROUP:
2
SELECT AGENT:
False
NIH PRIORITY
pathogens category:
non-BEI
Ordering Clones & Proteins
If there are materials available for this target, they will be listed below.
Materials can be ordered from SSGCID using the button in the "order material" column.
Clicking the button will add the material to a virtual cart.
You may order multiple materials at a time at no cost to you, as this contract is funded
by NIAID. When you are ready to place your order, click the "Place Order" link which will
appear in the top right corner of the page after you place your first item in your cart.
Clones*
CENTER
REFERENCE ID
DOMAIN/REGION
DESCRIPTION
INFO
AA
START
AA
STOP
ORDER
MATERIAL
ChtrA.00612.a.B1.GE41839
full length
info
1
526
ChtrA.00612.a.B1.GE41839
* SSGCID clones represent un-induced expression constructs which have been verified by sequencing from vector primers. Clones may contain a tag, such as N-term 6xHis . Get sequence information
using the button in the "info" column.
Proteins
CENTER REFERENCE ID
DOMAIN/REGION DESCRIPTION
INFO
AA START
AA STOP
ORDER MATERIAL
ChtrA.00612.a.B1.PW38393
full length
info
1
526
PW38393
Structures
6NRZ
DEPOSITED: 1/24/2019
DETERMINATION: XRay
CLONE: ChtrA.00612.a.B1.GE41839
PROTEIN: ChtrA.00612.a.B1.PW38393
6NS0
DEPOSITED: 1/24/2019
DETERMINATION: XRay
CLONE: ChtrA.00612.a.B1.GE41839
PROTEIN: ChtrA.00612.a.B1.PW38393
6O3F
DEPOSITED: 2/26/2019
DETERMINATION: XRay
CLONE: ChtrA.00612.a.B1.GE41839
PROTEIN: ChtrA.00612.a.B1.PW38393
Sequences
These sequences are the native gene sequence; sequences of constructs derived from these sequences may differ due to codon optimization or other protocols.
To find the specific sequence of any material you may have ordered, click on the "info" button next to the name of that material.
AA Sequence
MSVEVEYLQH EDYLYRTSKL KEIRDLGINP YPYQYTDCLE VQEIRNQFVD NELGDSEAAF RKETPKVRFA GRLVLFRSMG KNAFGQILDN DAKIQVMFNR DFSAVAGLAA DAGISPIKFI EKKLDLGDIL GLEGYLFFTH SGELTVLVET VTLLCKSLIS LPDKHAGLAD KEIRYRKRWA DLISSEDVRK TFLTRSRILK LIREYMDQQS FLEVETPILQ TVYGGAEATP FVTTLQALHA EMFLRISLEI ALKKLLVGGM SRVYEIGKVF RNEGIDRTHN PEFTMIEAYA AYWDYNDVMK CVENLVEYIV RALNNGETQV QYSHLKSGPQ VVDFKAPWIR MTMKESISVY GGVDVDLHAD HELRKILETQ TSLPEKTYVH ASRGELIALL FDELVCDKLI APHHITDHPL ETTPLCKTLR SGDETLVERF ESFCLGKELC NAYSELNDPL QQRKLLEEQM RKKALNPDSE YHPIDEEFLE ALCQGMPPAG GFGIGIDRLV MMLTDAASIR DVLFFPVMRR IEAKKD
NT Sequence
atgtctgtag aagttgaata cttgcaacac gaagattatt tgtatagaac aagcaagcta aaggaaatca gagatttggg cataaatcct tacccttatc aatacactga ttgtcttgaa gtacaggaaa ttcgtaatca gtttgtagat aacgaattag gagatagcga agcggctttt cgtaaagaga cacctaaggt gcgttttgcc ggacgacttg ttcttttccg ttctatgggg aaaaatgctt ttgggcagat cctcgataat gatgcaaaga ttcaagtgat gttcaatcga gatttttctg cagtggcagg gttagccgcg gatgctggga tttctccgat taaatttatt gagaagaaac ttgatctagg agacatcttg ggtctcgaag ggtatctttt ctttactcac tcaggagaat taacggttct cgttgaaacg gtaacgttgt tatgtaaatc cttaatttct ttgcctgata agcatgcagg attagcagat aaagaaattc gctatcgcaa acgttgggca gatctgattt cctcagagga tgtgcgtaag actttcttaa caagaagccg gattcttaag ttgattcgtg agtacatgga tcagcagagc tttttagagg tggaaactcc tatcttgcaa accgtctacg gaggagcaga agcaactcct tttgttacca cgctgcaagc gctacatgca gaaatgttcc taagaatttc tctagagatt gctttgaaaa aactccttgt tggaggaatg tcccgagttt atgaaatcgg caaagttttc cgtaacgaag gaatcgatag aacgcataat ccagagttta ccatgataga ggcttatgcg gcttattggg attacaatga tgtaatgaaa tgtgtggaaa accttgttga gtatatcgta cgtgctttga ataacgggga aactcaggtt cagtattcac atttaaaatc aggacctcag gttgttgatt ttaaagctcc atggatccgt atgacgatga aagaaagtat ctctgtctat ggcggcgtcg atgtagactt acatgcagat catgaattac gtaaaatttt agaaacacaa acatctcttc cagagaaaac gtatgttcat gcctcacgag gagagctgat cgctttgcta tttgatgagc tggtttgtga taagctcatc gctccgcatc acattacaga tcatccatta gaaacaacgc cactttgtaa aacattgcgt tctggggatg aaactctggt agaacgattt gagagttttt gtttaggaaa agagttgtgt aatgcttatt cggaactcaa tgatccttta caacaacgaa aattgttgga agagcaaatg cgtaaaaagg ctttaaatcc tgacagcgaa taccatccta tagatgaaga atttctagaa gctctttgcc aaggaatgcc tcctgcagga ggatttggaa taggtatcga tcgattggtt atgatgttga cagacgctgc atccattcgg gatgtcctgt ttttccctgt tatgcggcgt atagaagcaa aaaaagatta a
Details for ChtrA.00612.a.B1.GE41839
HARVESTED ON:
8/31/2017
SEQUENCED ON:
9/29/2017
EXPECTED MW:
61kDa
OBSERVED MW:
62kDa
ANTIBIOTIC MARKER:
ampicillin
COUNT OF EXPRESSION COLONIES:
Good (10-50)
TOTAL EXPRESSION LEVEL:
High Expression
SOLUBLE EXPRESSION LEVEL
High Expression
EXPRESSION HOST:
BL 21 (DE3) Rosetta
SEQUENCING RESULT:
PERCENT IDENTITY:
99
PERCENT COVERAGE:
100
Details for ChtrA.00612.a.B1.PW38393
PURIFICATION DATe:
11/15/2017
CONCENTRATION:
25.76mg/ml
OBSERVED MW:
61kDa
EXPRESSION LEVEL:
Moderate Expression
PROTEIN PURIFICATION BUFFER:
25 mM HEPES pH 7.0, 500 mM NaCl, 5% Glycerol , 2 mM DTT, 0.025% Azide
EXPRESSION HOST:
BL 21 (DE3) Rosetta
VIAL COUNT (approx.):
16
VIAL VOLUME:
200µl
PERCENT IDENTITY:
99
PERCENT COVERAGE:
100